SCI covering letter 及投稿经验总结

Dr. XU Jianhe

The State Key Laboratory of Bioreactor Engineering

East China University of Science and Technology, Shanghai 200237, China Tel: +86-21-64252498; Fax: +86-21-64252250

Elsevier 投稿各种状态总结

1. Submitted to Journal当上传结束后，显示的状态是Submitted to Journal，这个状态是自然形成的无需处理。

2. With editor如果在投稿的时候没有要求选择编辑，就先到主编那，主编会分派给别的编辑。这当中就会有另两个状态： 3. Editor assigned

4. Editor Declined Invitation 如果编辑接手处理了就会邀请审稿人了。 5. Reviewer(s) invited

如果审稿人接受那就会是以下状态： 6. Under review

这应该是一个漫长的等待。当然前面各步骤也可能很慢的，要看编辑的处理情况。 如果被邀请审稿人不想审，就会decline，编辑会重新邀请别的审稿人。 7. required review completed 审稿结束，等编辑处理。

8. Decision in Process到了这一步就快要有结果了，编辑开始考虑是给修改还是直接拒，当然也有可能直接接受的，但可能性很小，呵呵。

9. Minor revision/Major revision这个时候可以稍微庆祝一下了，问题不大了，因为有修改就有可能。具体怎么改就不多说了，谦虚谨慎是不可少的。 10. Revision Submitted to Journal 又开始了一个循环。

11. Accepted如果不要再审，只是小修改，编辑看后会马上显示这个状态，但如果要再审也会有上面的部分状态。一步会比较快，但也有慢的。看杂志的。

还有个状态是Rejected。希望不要出现。

其他库的状态，基本是大同小异，供参考：

In the Rapid Review? system, your manuscript has a different status assigned to it at various stages in the process. Below is a list of the status descriptions used

with brief explanations.

Incomplete Submission... you have begun the submission process. The submission has been assigned a temporary (TMP) manuscript number. You must complete the submission process.

Finish My Submission... by viewing and approving the MS PDF. Once this is done, the submission will be assigned a permanent manuscript number.

MS at Check-In... the manuscript is pending a quality check by the staff or editor. This involves verifying that the MS PDF contains a complete manuscript (text, tables, figures, etc.) and is suitable for review purposes.

Conversion to PDF in Process... If the manuscript was submitted digitally, the MS PDF did not pass the QC process and is not suitable for review purposes. The staff may be in the process of converting the digital files to a new MS PDF or staff may have requested that the author send new file(s). The Journal Office is waiting for the file(s) to upload for conversion purposes.

MS Being Pre-screened... if you submitted a manuscript to a journal whose review process includes pre-screening, this status indicates that the manuscript (or the abstract) is currently being pre-screened to determine its appropriateness for the journal.

MS In Review... the manuscript has been assigned to an editor and may be awaiting reviewer selections, or the awaiting reviews.

Decision Pending... the manuscript has been reviewed and the editor is in the process of making a decision.

MS in Revision (Optional)... a decision to accept the paper with optional revisions (as suggested in the reviewer or editor comments) has been made by the editor, and a letter requesting these revisions has been sent to the author. Resubmission is anticipated.

MS in Revision (Minor)... a decision to accept the paper with minor revisions (as suggested in the reviewer or editor comments) has been made by the editor, and a letter requesting these revisions has been sent to the author. Resubmission is anticipated.

MS in Revision (Major)... a decision to reconsider the paper after major revisions (as suggested in the reviewer or editor comments) has been made by the editor, and a letter requesting these revisions has been sent to the author. Resubmission is permitted.

MS Rejected... a decision to decline publication has been made by the editor, and a rejection letter has been sent to the author.

MS Accepted... a decision to accept the paper has been made by the editor, and an acceptance letter has been sent to the author.

MS Withdrawn... the manuscript has been withdrawn at the author's request. No resubmission is permitted. Any further version must be considered as a brand new submission.

MS Deactivated... the manuscript has been deactivated due to the author's non-response in resubmitting a revised version or, in some instances, to the editor's invitation to submit a solicited paper.

MS Published... the review process is complete and the manuscript is awaiting publication or it has already been published.

Invitation/Submit Invited Paper... the editor has extended to you an invitation to submit a paper on a proposed topic. You are asked to reply by using the \Invitation\button. If you and the editor are in agreement, you can submit the invited paper by using the \

It can be concluded from the discussion that

cover letter包含的内容比较丰富，比如作者信息，论文信息，推荐审稿人，论文创新之处等。

comments写写与你论文相关的内容，主要还是吹自己的工作。

作者: bioman 发布日期: 2006-10-27 还有，cover letter有些是审稿人可见的，comment是不对审稿人开放的。 E-mail: jianhexu@ecust.edu.cn

SCI投稿信件的一些套话 整理收藏 ：）

作者: andyfu125 发布日期: 2007-9-20 查看数: 5267 出自: http://emuch.net

一、投稿信

1. Dear Dr. Defendi ML:

I am sending a manuscript entitled “” by – which I should like to submit for possible publication in the journal of - . Yours sincerely

2. Dear Dr. A:

Enclosed is a manuscript entitled “” by sb, which we are submitting for publication in the journal of - . We have chosen this journal because it deals with - . We believe that sth would be of interest to the journal’s readers.

3. Dear Dr. A:

Please find enclosed for your review an original research article, “” by sb. All authors have read and approve this version of the article, and due care has been taken to ensure the integrity of the work. No part of this paper has published or submitted elsewhere. No conflict of interest exits in the submission of this manuscript, and we have attached to this letter the signed letter granting us permission to use Figure 1 from another source.

We appreciate your consideration of our manuscript, and we look forward to receiving comments from the reviewers.

二、询问有无收到稿件 Dear Editors,

We dispatched our manuscript to your journal on 3 August 2006 but have not, as yet, receive acknowledgement of their safe arrival. We fear that may have been lost and should be grateful if you would let us know whether or not you have received them. If not, we will send our manuscript again. Thank you in advance for your help.

三、询问论文审查回音 Dear Editors，

It is more than 12 weeks since I submitted our manuscript (No: ) for possible publication in your journal. I have not yet received a reply and am wondering whether you have reached a decision. I should appreciated your letting me know what you have decided as soon as possible.

Dear Editors:

It is nearly 6 weeks since the “Current Status” of our manuscript (No: ENZMICTEC-D-09-00623) has been “Under Review” in your journal (Enzyme and Microbial Technology). I would really appreciate it if you inform us what you have decided as soon as possible. Thank you very much!

Kind regards

Yours sincerely Chun Li

Corresponding Author: Li Chun

Corresponding Author's Institution:

School of Life Science, Beijing Institute of Technology e-mail: lichun@bit.edu.cn Tel: +8610-68913171

四、关于论文的总体审查意见

1. This is a carefully done study and the findings are of considerable interest. A few minor revision are list below. 2. This is a well-written paper containing interesting results which merit publication. For the benefit of the reader, however, a number of points need clarifying and certain statements require further justification. There are given below.

3. Although these observation are interesting, they are rather limited and do not advance our knowledge of the subject sufficiently to warrant publication in PNAS. We suggest that the authors try submitting their findings to specialist journal such as –

4. Although this paper is good, it would be ever better if some extra data were added.

5. This manuscript is not suitable for publication in the journal of – because the main observation it describe was reported 3 years ago in a reputable journal of - .

6. Please ask someone familiar with English language to help you rewrite this paper. As you will see, I have made some correction at the beginning of the paper where some syntax is not satisfactory.

7. We feel that this potentially interesting study has been marred by an inability to communicate the finding correctly in English and should like to suggest that the authors seek the advice of someone with a good knowledge of English, preferable native speaker.

8. The wording and style of some section, particularly those concerning HPLC, need careful editing. Attention should be paid to the wording of those parts of the Discussion of and Summary which have been underlined.

9. Preliminary experiments only have been done and with exception of that summarized in Table 2, none has been repeated. This is clearly unsatisfactory, particularly when there is so much variation between assays. 10. The condition of incubation are poorly defined. What is the temperature? Were antibody used?

五、给编辑的回信

1. In reply to the referee’s main criticism of paper, it is possible to say that –

One minor point raised by the referee concerns of the extra composition of the reaction mixture in Figure 1. This has now been corrected. Further minor changes had been made on page 3, paragraph 1 (line 3-8) and 2 (line 6-11). These

do not affect our interpretation of the result.

2. I have read the referee’s comments very carefully and conclude that the paper has been rejected on the sole grounds that it lake toxicity data. I admit that I did not include a toxicity table in my article although perhaps I should have done. This was for the sake of brevity rather than an error or omission.

3. Thank you for your letter of – and for the referee’s comments concerning our manuscript entitled “”. We have studied their comments carefully and have made correction which we hope meet with their approval.

4. I enclosed a revised manuscript which includes a report of additional experiments done at the referee’s suggestion. You will see that our original findings are confirmed.

5. We are sending the revised manuscript according to the comments of the reviewers. Revised portion are underlined in red.

6. We found the referee’s comments most helpful and have revised the manuscript 7. We are pleased to note the favorable comments of reviewers in their opening sentence.

8. Thank you for your letter. I am very pleased to learn that our manuscript is acceptable for publication in Cancer Research with minor revision.

9. We have therefore completed a further series of experiments, the result of which are summarized in Table 5. From this we conclude that intrinsic factor is not account.

10. We deleted the relevant passage since they are not essential to the contents of the paper.

11. I feel that the reviewer’s comments concerning Figures 1 and 2 result from a misinterpretation of the data. 12. We would have include a non-protein inhibitor in our system, as a control, if one had been available.

13. We prefer to retain the use of Table 4 for reasons that it should be clear from the new paragraph inserted at the end of the Results section.

14. Although reviewer does not consider it is important to measure the temperature of the cells, we consider it essential.

15. The running title has been changed to “”.

16. The Materials and Methods section now includes details for measuring uptake of isotope and assaying hexokinase.

17. The concentration of HAT media (page12 paragraph 2) was incorrectly stated in the original manuscript. This has been rectified. The authors are grateful to the referees for pointing out their error.

18. As suggested by both referees, a discussion of the possibility of laser action on chromosome has been included (page16, paragraph 2).

19. We included a new set of photographs with better definition than those originally submitted and to which a scale has been added.

20. Following the suggestion of the referees, we have redraw Figure 3 and 4.

21. Two further papers, published since our original submission, have been added to the text and Reference section. These are:

22. We should like to thank the referees for their helpful comments and hope that we have now produced a more balance and better account of our work. We trust that the revised manuscript is acceptable for publication.

23. I greatly appreciate both your help and that of the referees concerning improvement to this paper. I hope that the revised manuscript is now suitable for publication.

24. I should like to express my appreciation to you and the referees for suggesting how to improve our paper. 25. I apologize for the delay in revising the manuscript. This was due to our doing an additional experiment, as suggested by referees.

对国外杂志投稿时如何写email

对国外杂志投稿的时候，一般都是使用email投递，除了正文文章作为附件发送以外，还需要写一封信，叫cover letter，一封好的cover letter可以起到很好的作用，就好比你求职的时候的自荐信，要吸引住编辑的眼球，你就成功一半了。国外杂志编辑的权利很大，基本决定你的生死。 cover letter的内容主要需要想编辑详细的介绍你的文章的主要内容，突出文章的创新性，价值，还有你为什么要发表这篇文章，还可以简要指出目前该领域的发展方向，最好你的文章就是朝向这个方向的。其他就是常规要求了，用语恰当，格式规范等。 Dear Dr．：

Enclosed are three copies of a manuscript by Rose N ．Dipaola，Donna A．Gallo，and Tom N．Roberts titled“Hepatitis C Virus Infection in Long-Term Transfusion Patients”．It is submitted to be considered for publication as a“Original Article\．This paper is～?Neither the entire paper nor any part of its content has been published or has been accepted elsewhere ．It is not being submitted to any other journal．

We believe the paper may be of particular interest to the readers of your journal because the study it reports stated the HCV infection rate among long-term transfusion patients is higher than that of the general population and of short-term transfusion patients．

Correspondence and phone calls about the paper should be directed to Rose N．Dipaola at the following address，phone and fax number，and e-mail address： Rose N ．Dipaola，MD Institute of Internal Medicine

Prof. Dr. An Ping Zeng

Head of Research Group: Systems Biology +49 (0) 531 6181-5323 +49 (0) 531 6181-5397 Contact

Cleveland Clinic Foundation 9500 Euclid Ave．

Cleveland，OH44195，USA Tel：1-216-444-5360 Fax：1-216-444-9580

E-mail：dipao＠cesmtp ．ccf. Org

Thanks very much for your attention to our paper． Sincerely yours， Rose N．Dipaola

1、 什么是cover letter？ 指的是投稿信

2、cover letter的内容主要包括那些？

应该简述所投稿件的核心内容、主要发现和意义，拟投期刊，对稿件处理有无特殊要求等（如“not to review” list）。另外，请附上主要作者的中文姓名、通讯地址、电话、传真和e-mail地址。此外有的杂志要求推荐几位审稿人及其联系方式。以及谁已经阅读过该文（当然是牛人）。

我投的那个杂志是要求说明你论文研究的意义，以及与这个杂志的相关性，另外还有的可能要写明你没有一搞多投等。此外临床实验要求写明符合伦理学要求。 3、 如何写cover letter？

各个杂志的具体要求是不一样的，在杂志的guide for authors一般会有要求。如果没有具体的要求，大家可按照通用要求处理。 4、常用模板： （1） Cover letter Dear Mr. **

1. The work described has not been submitted elsewhere for publication, in whole or in part, and all the authors listed have approved the manuscript that is enclosed. 2. I have read and have abided by the statement of ethical standards for manuscripts submitted to Neuroscience.

kind regards. Your sincerely, 通讯作者 （2）

Dear Dr. 主编name:

We submit our manuscript entitled \文章title\杂志名for publication. 接着简单介绍你文章的主要创新点和意义，不易过多，但要突出新意和关键点。 All authors have seen the manuscript and approved to submit to your journal. Thank you very much for your attention and consideration. Sincerely yours, 通讯作者 （3）

Dear Dr. 主编name:

We submit our manuscript entitled \文章title\杂志名for publication. 接着简单介绍你文章的主要创新点和意义，不易过多，但要突出新意和关键点。 All authors have seen the manuscript and approved to submit to your journal. Thank you very much for your attention and consideration. Sincerely yours, 通讯作者 （4）Dr. *** Editor-in-Chief, ***

(add address) January 22, 2003 Dear Dr. **,

Enclosed herewith please find 3 copies of a MS by: ‘***. *** and ***’ entitled: “**********”, which we would like to submit for publication in the ‘******'. Looking forward to your decision, With kind personal regards, Sincerely yours, *****

Professor of *** （5）

Dear Prof. Gil:

This is a manuscript by**and **entitled “.......”. It is submitted to be considered for publication as a “...” in your journal. This paper is new. Neither the entire paper nor any part of its content has been published or has been accepted elsewhere. It is not being submitted to any other journal.

We believe the paper may be of particular interest to the readers of your journal as it ........

Correspondence should be addressed to **at the following address, phone and fax number, and email address: ...

Thanks very much for your attention to our paper. Sincerely yours, **

5、 例文：下面例文都来自丁香园战友，在此一并感谢。 （一）

Date: Sep 15, 2003 Dear Editors:

On behalf of my co-authors, I am submitting the enclosed material “ TITLE ” for possible publication in JOURNAL.

We certify that we have participated sufficiently in the work to take public responsibility for the appropriateness of the experimental design and method, and the collection, analysis, and interpretation of the data.

We have reviewed the final version of the manuscript and approve it for publication. To the best of our knowledge and belief, this manuscript has not been published in whole or in part nor is it being considered for publication elsewhere. Best Regards. Yours Sincerely, NAME,ADRESS,EMAIL,FAX （二）

Dear Dr Regino Perez-Polo：

Enclosed are a manuscript by su jian, yang kun, chen zhihua．Su jian titled“Hypothermia after Acute Ischemic Stroke

”．It is submitted to be considered for publication as a“review\in your

journal．This paper is～&S226;Neither the entire paper nor any part of its content has been published or has been accepted elsewhere ．It is not being submitted to any other journal．

We believe the paper may be of particular interest to the readers of your journal. Correspondence and phone calls about the paper should be directed to Su jian at the following address，phone and fax number，and e-mail address： Su jian Institute:, Adress: Tel： Fax: E-mail：

Thanks very much for your attention to our paper． Sincerely yours， Su jian （三） Dear Editor,

We would like to submit the enclosed manuscript entitled \Neuronal Excitability and A-type Potassium Channels in Midbrain Dopaminergic Neurons\GDNF has long been thought to be a potent neurotrophic factor for the survival of midbrain dopaminergic neurons, which are degenerated in Parkinson’s disease. In this paper, we report an unexpected, acute effect of GDNF on A-type potassium channels, leading to a potentiation of neuronal excitability, in the dopaminergic neurons in culture as well as in adult brain slices. Further, we show that GDNF regulates the K+ channels through a mechanism that involves activation of MAP kinase. Thus, this study has revealed, for the first time, an acute modulation of ion channels by GDNF. Our findings challenge the classic view of GDNF as a long-term survival factor for midbrain dopaminergic neurons, and suggest that the normal function of GDNF is to regulate neuronal excitability, and consequently dopamine release. These results may also have implications in the treatment of Parkinson’s disease.

Due to a direct competition and conflict of interest, we request that Drs. XXX of Harvard Univ., and YY of Yale Univ. not be considered as reviewers. With thanks for your consideration, I am Sincerely yours, （四） Dear **.

We would like to submit the enclosed manuscript entitled \be considered for publication in **journal.

We believe that two aspects of this manuscript will make it interesting to general readers of **journal. First, ***. Second, ***. Further, ***.

Thank you very much your considering our manuscript for potential publication. I'm looking forward to hearing from you soon. Best wishes. （五）

To: SOLA Chief Editor

Division of Geoenvironmental Sciences University of Tsukuba Tsukuba 305-8572, JAPAN

E-Mail: sola@sakura.cc.tsukuba.ac.jp Dear Sirs,

I am sending herewith a copy of the manuscript, which I would like to submit to SOLA, the Electronic Journal of the Meteorological Society of Japan. The paper is entitled:

Energy Spectrum Proportional to the Squared Phase Speed of Rossby Modes in the General Circulation of the Atmosphere by H. L. Tanaka, Yasushi Watarai, and Takahiro Kanda. Copy of the Abstract:

In this study, energy spectrum of the large-scale atmospheric motions is examined in the framework of the 3D normal mode decomposition. The horizontal scale of disturbance is measured by the phase speed of a Rossby mode c. According to the analysis result for the barotropic component of the atmosphere, we obtain a characteristic energy spectrum with distinct slopes for the turbulence and wave

regimes separated by the spherical Rhines speed. In order to explain the observational finding that the energy spectrum is proportional to c^2, we put forward a hypothesis based on the criterion of Rossby wave breaking such that the local meridional gradient of potential vorticity becomes negative, dq/dy < 0, somewhere in the domain. With a constant m describing a total mass of the atmosphere for unit area, we have shown that the barotropic energy spectrum of the general circulation E can be represented as E=mc^2. Corresponding Author: Dr. Hiroshi L. Tanaka

Division of Geoenvironmental Sciences University of Tsukuba Tsukuba 305-8572, JAPAN Tel: +81-29-853-4502 Fax: +81-29-853-6879

E-Mail: tanaka@sakura.cc.tsukuba.ac.jp

I hereby certify that this paper consists of original, unpublished work which is not under consideration for publication elsewhere. Desired Editors in Charge:

Kimoto, Masahide University of Tokyo Mak, Mankin University of Illinois Five Potential Reviewers: Name-1, e-mail address-1 Name-2, e-mail address-2 Name-3, e-mail address-3 Name-4, e-mail address-4 Name-5, e-mail address-5

The original manuscript and figures will be transferred, following the instruction by the Editorial Committee when the paper is accepted. I hope your favorable consideration for publication to SOLA. Sincerely, Hiroshi L. Tanaka

Attachment: PDF file of the manuscript.

Dear Editor,

We would like to submit the enclosed manuscript entitled \and A-type Potassium Channels in Midbrain Dopaminergic Neurons\publication in Nature Neuroscience.

GDNF has long been thought to be a potent neurotrophic factor for the survival of midbrain dopaminergic neurons, which are degenerated in Parkinson’s disease. In this paper, we report an unexpected, acute effect of GDNF on A-type potassium channels, leading to a potentiation of neuronal excitability, in the dopaminergic neurons in culture as well as in adult brain slices. Further, we show that GDNF regulates the K+ channels through a mechanism that involves activation of MAP kinase. Thus, this study has revealed, for the first time, an acute modulation of ion channels by GDNF. Our findings challenge the classic view of GDNF as a long-term survival factor for midbrain dopaminergic neurons, and suggest that the normal function of GDNF is to regulate neuronal excitability, and consequently dopamine release. These results may also have implications in the treatment of Parkinson’s disease.

Due to a direct competition and conflict of interest, we request that Drs. XXX of Harvard Univ., and YY of Yale Univ. not be considered as reviewers. With thanks for your consideration, I am

Sincerely yours, case2 Dear Editor,

We would like to submit the enclosed manuscript entitled \protein frequenin mediates GDNF-induced potentiation of Ca2+ channels and transmitter release\for publication in Neuron.

We believe that two aspects of this manuscript will make it interesting to general readers of Neuron. First, we report that GDNF has a long-term regulatory effect on neurotransmitter release at the neuromuscular

synapses. This provides the first physiological evidence for a role of this new family of neurotrophic factors in functional synaptic transmission. Second, we show that the GDNF effect is mediated by enhancing the expression of the Ca2+-binding protein frequenin. Further, GDNF and frequenin facilitate synaptic transmission by enhancing Ca2+ channel activity, leading to an enhancement of Ca2+ influx. Thus, this study has identified, for the first time, a molecular target that mediates the long-term, synaptic action of a neurotrophic factor. Our findings may also have general implications in the cell biology of neurotransmitter release.

[0630][投稿写作]某杂志给出的标准Sample Cover Letter[the example used is the IJEB] Case 3

Sample Cover Letter[the example used is the IJEB]

Dear Editor of the [please type in journal title or acronym]:

Enclosed is a paper, entitled \for publication in the [journal title]. Below are our responses to your submission requirements.

1. Title and the central theme of the article.

Paper title: \and distributed network management system. It proposes a mobile agent-based implementation framework and creates a prototype system to demonstrate the superior performance of a mobile agent-based network over the conventional client-server architecture in a large network environment.

2. Which subject/theme of the Journal the material fits

New enabling technologies (if no matching subject/theme, enter 'Subject highly related to [subject of journal] but not listed by [please type in journal title or acronym])

3. Why the material is important in its field and why the material should be published in [please type in journal title or acronym]?

The necessity of having an effective computer network is rapidly growing alongside the implementation of information technology. Finding an appropriate network management system

has become increasingly important today's distributed environment. However, the conventional centralized architecture, which routinely requests the status information of local units by the central server, is not sufficient to manage the growing requests. Recently, a new framework that uses mobile agent technology to assist the distributed management has emerged. The mobile agent reduces network traffic, distributes management tasks, and improves operational performance. Given today's bandwidth

demand over the Internet, it is important for the [journal title/acronym] readers

to understand this technology and its benefits. This study gives a real-life example of how to use mobile agents for distributed network management. It is the first in the literature that reports the analysis of network performance based on an operational prototype of mobile agent-based distributed

network. We strongly believe the contribution of this study warrants its publication in the [journal title/acronym].

4. Names, addresses, and email addresses of four expert referees. Prof. Dr. William Gates

Chair Professor of Information Technology 321 Johnson Hall

Premier University Lancaster, NY 00012-6666, USA

phone: +1-888-888-8888 - fax: +1-888-888-8886 e-mail: wgates@lancaster.edu

Expertise: published a related paper (\38(3), pp. 188-198.

Relationship: I met Dr. Gate only once at a conference in 1999. I didn't know him personally. Assoc Prof. Dr. John Adams Director of Network Research Center College of Business Australian University 123, Harbor Drive Sydney, Australia 56789

phone: +61-8-8888-8888 - fax: +61-8-8888-8886 e-mail: jadams@au.edu.au

Expertise: published a related paper (\Relationship: None. I have never met Dr. Adams. Assoc Prof. Dr. Chia-Ho Chen Chair of MIS Department College of Management Open University 888, Putong Road Keelung, Taiwan 100

phone: +886-2-8888-8888 - fax: +886-2-8888-8886 e-mail: chchen@ou.edu.tw

Expertise: published a related paper (\Management for E-Commerce\Business, 1(4), pp. 18-28.

Relationship: Former professor, dissertation chairman. Mr. Frank Young Partner, ABC Consulting 888, Seashore Highway Won Kok, Kowloon Hong Kong

phone: +852-8888-8888 - fax: +852-8888-8886 e-mail: fyoung@abcc.com

Expertise: Mr. Young provides consulting services extensively to his clients regarding network

in IJ Electronic

in IEEE TOSE, 18(8), pp. 88-98.

in CACM,

management practices.

Relationship: I have worked with Mr. Young in several consulting projects in the past three years.

Finally, this paper is our original unpublished work and it has not been submitted to any other journal for reviews.

Sincerely,

Johnny Smith

本文来源：https://www.bwwdw.com/article/hin8.html